Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)
Authors
Keywords
HPV-16, Antigens, Human papillomavirus, Immune response, Enzyme-linked immunoassays, Human papillomavirus infection, T cells, Vaccines
Journal
PLoS One
Volume 9, Issue 11, Pages e113461
Publisher
Public Library of Science (PLoS)
Online
2014-11-26
DOI
10.1371/journal.pone.0113461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
- (2012) S. N. Tabrizi et al. JOURNAL OF INFECTIOUS DISEASES
- Erratum: Regulation of cytoplasmic mRNA decay
- (2012) Daniel R. Schoenberg et al. NATURE REVIEWS GENETICS
- Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7
- (2012) F.E. Henken et al. VACCINE
- Human Papillomavirus Vaccine Introduction – The First Five Years
- (2012) Lauri E. Markowitz et al. VACCINE
- Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7
- (2011) Koen Oosterhuis et al. INTERNATIONAL JOURNAL OF CANCER
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
- (2011) Troy J. Kemp et al. VACCINE
- Human papillomavirus-specific immune therapy: failure and hope
- (2010) Karen Nieto et al. ANTIVIRAL THERAPY
- Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
- (2010) S Daayana et al. BRITISH JOURNAL OF CANCER
- Therapeutic HPV DNA vaccines
- (2010) Ken Lin et al. IMMUNOLOGIC RESEARCH
- The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA
- (2010) Peter Öhlschläger et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Persistence of human papillomavirus infection: keys to malignant progression
- (2010) Jason Bodily et al. TRENDS IN MICROBIOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA vaccine against human papillomavirus type 16: Modifications of the E6 oncogene
- (2009) Ingrid Poláková et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More